Skip to main content
. 2000 Jun;44(6):1428–1437. doi: 10.1128/aac.44.6.1428-1437.2000

FIG. 5.

FIG. 5

Increase in SLU by the fnbB-luxAB reporter plasmid in strain EN1252a(pFNBB6) or ISP794(pFNBB6) exposed for 20 min to either control MHB or MHB supplemented with rifampin (2 μg/ml), with one-quarter the MIC (8 μg/ml) of ciprofloxacin, or with rifampin (2 μg/ml) followed by ciprofloxacin (8 μg/ml).